Rovedar Publication ensures some policies for authors about the publication and distribution of an article. The author, should be aware of policies before the submission of an article. Please read the following policies about Copyright, Article Sharing, Article Withdrawal, Article Retraction, Article Removal and Article Replacement.
The authors sign a copyright declaration form with Rovedar Publication thereby rendering publication and distribution rights. By this agreement, they also retain significant rights to use and share their own published article. All the publisher and authors’ rights are mentioned in the form. Rovedar Publication retains unlimited rights to publish and distribute the published article by this agreement. The copyright declaration transfer form covers the exclusive rights to reproduce and distribute the article, including reprint, translation, photographic reproduction, microform, electronic form (online, offline), or any other reproduction of similar nature.
When a paper is published, it will be shared on several platforms that are the most important ones and help the author get more citations, audience, visibility, and reputation and thus promotes the author in his professional career. The following ways will also help the author(s) to promote their work after publication. The author(s) may:
- consider search engine optimization and keywords to help readers to discover your article.
- share the paper on press and social media. A sharing option is available on every page of published articles.
- share the article on your personal website or blog.
- share the article on any indexing database or institutional repository.
Open access agreement
All the Rovedar Journals are Gold Open Access and provide immediate open access to the content (articles) published in the journal, on the principle that making research freely available on the Internet to support a greater global exchange of knowledge. The authors are also required to grant Rovedar Journals open access publication of their article with a Creative Commons Attribution license (CC BY; http://creativecommons.org/licenses/by/4.0) license, which permits unrestricted use, share, distribution, and reproduction in any platform and medium, provided that the original work is properly cited. In particular, although the website indicates CC BY licensing and copyright remains with authors, articles clearly note copyright is held by the publisher.
Withdrawal, retraction, removal, or replacement of a published article
Rovedar Publication understands the importance of completeness of the scholarly record for researchers and librarians and gives the highest importance to maintaining trust in the authority of its electronic archive. In very occasional cases, it comes necessary to withdraw, retract, remove or replace a published article. Such cases are not taken very lightly. Rovedar Publication follows some strict specific rules and policies mentioned below:
After submission, when the author(s) needs to withdraw their article(s) due to some reasons, the journal editor investigates the matter, the step of the peer-review process, and the reason for withdrawal. All the withdrawal requests within ONE week of submission will be accepted and the manuscript will be deleted from the journal database. In case the author(s) are paid the APC but demands withdrawal of articles in Press (those have been accepted for publication but which have not been formally published and will not yet have the complete volume/issue/page information), the manuscript may be withdrawn from our database but the publication fee will not be refunded. The withdrawal requests because of simultaneous submissions to other journals especially when the article is under peer-review process, will not be accepted. After the peer-reviewing step, the editor processes the withdrawal after investigating the matter. In case of multiple submissions, bogus claims of authorship, duplication, plagiarism, fraudulent use of data, or the like that are determined to violate Rovedar journal publishing ethics guidelines, the article may also be withdrawn from our database. It means that the article content (HTML, XML, and PDF) is removed and replaced with a statement (the article has been withdrawn according to the Rovedar Policy on Article in Press Withdrawal) with a link to the current policy document.
In case of infringements of professional ethical codes, such as multiple submissions, bogus claims of authorship, duplication, plagiarism, fraudulent use of data or the like that are determined to violate Rovedar journal publishing ethics guideline, a retraction will be used to correct errors in submission or publication. Rovedar Publication Company will consider retracting a publication if:
- It has clear evidence that the findings are unreliable, either as a result of misconduct (e.g. data fabrication) or honest error (e.g. miscalculation or experimental error);
- The findings have previously been published elsewhere without proper crossreferencing, permission, or justification (i.e. cases of redundant publication);
- It constitutes plagiarism;
- It reports unethical research.
The following standards for dealing with retractions are adopted based on a number of library and scholarly bodies and COPE’s Best Practice Guidelines for Journal Editors:
- A retraction note signed by both authors and editor is published in the specific part of a subsequent issue of the journal and listed in the contents list;
- A link is made to the original published article to help the reader see both the retraction note and the article itself;
- A titled “retracted” watermark on the .pdf is added on each page without any change to the original article;
- The HTML, XML, and ePrint version of the document is removed.
Article removal (because of legal limitations)
In a limited number of cases, it may be necessary to remove an article from the online database so that the “Title and Authors” will be retained, and only the text will be replaced with a screen indicating the article has been removed for legal reasons. This will only occur where the article is clearly defamatory or infringes others’ legal rights, or where the article is, or we have good reason to expect it will be, the subject of a court order, or where the article if acted upon, might pose a serious health risk.
In case, where an article might pose a serious health risk, the author(s) can replace theır article(s) with a correct version. In this case, we will post a notice with a link to the corrected re-published article (plus a history of the document if necessary).
Peer Review Policy
The practice of peer review is to ensure that only good science is published. It is an objective process at the heart of good scholarly publishing and is carried out by all reputable scientific journals. Our reviewers play a vital role in maintaining the high standards Review Policy and all manuscripts are peer-reviewed following the procedure outlined below.
Initial manuscript evaluation
The Editor first evaluates all manuscripts. It is rare, but it is possible for an exceptional manuscript to be accepted at this stage. Manuscripts rejected at this stage are insufficiently original, have serious scientific flaws, have poor grammar or English language, or are outside the aims and scope of the journal. Those that meet the minimum criteria are normally passed on to at least 2 experts for review.
Type of Peer Review
Rovedar journals employs single-blind reviewing policy.
How the reviewer is selected
Whenever possible, reviewers are matched to the paper according to their expertise and our database is constantly being updated.
Reviewers are asked to evaluate whether the manuscript: – Is original – Is methodologically sound – Follows appropriate ethical guidelines – Has results which are clearly presented and support the conclusions – Correctly reviewers previous relevant work.
Language correction is not part of the peer-review process, but reviewers may, if so wish, suggest corrections to the manuscript.
How long does the review process take?
The time required for the review process is dependent on the response of the reviewers. Should the reviewers’ reports contradict one another or a report is unnecessarily delayed, a further expert opinion will be sought. The Editor’s decision will be sent to the author with recommendations made by the reviewers, which usually include verbatim comments by the reviewers. Revised manuscripts might be returned to the initial referees who may then request another revision of a manuscript.
A final decision to accept or reject the manuscript will be sent to the author along with any recommendations made by the reviewers and may include verbatim comments by the reviewers.
Editor’s Decision is final
Reviewers advise the editor, who is responsible for the final decision to accept or reject the article.
We are a ‘gold’ publisher. Rovedar publisher allows self-archiving and website archiving.
All of our electronic content (website, manuscripts, etc.) is stored on two different sources. Content on one server is online and accessible to the readers. The copy of the same content is kept as a backup on the other source. In case of failure of one server, any one of the other sources can be made online and the website is expected to be accessible within less than 24-36 hours.
Authors may archive the final published version of their articles in personal or institutional repositories immediately after publication.
Statement of Informed Consent
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki. Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals , and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number. For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal. Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please also refer to the ICMJE Recommendations for the Protection of Research Participants. All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.
The articles in Rovedar journals are open-access.
By accessing this website, downloading, printing, or reading any article published in the Journal, you are stating that you agree to all of the following terms and conditions:
- In no event shall the Journal, its publisher, editors, or anyone involved in the journal be liable to you or any other party on any legal theory, for any special, incidental, consequential, punitive, exemplary, or any damages whatsoever arising out of or in connection with the use of any material in this web site or material published in the Journal, whether or not advised of the possibility of damage.
- The content of this website and the materials published in the journal are provided “as is” without warranty of any kind, either expressed or implied, including, but not limited to, the implied warranties of merchantability, fitness for a particular purpose, non-infringement, accuracy, completeness, or absence of errors.
- Statements or methods presented in the articles are those of the authors and do not constitute an endorsement by the editors or the publisher. The information contained in the articles must not be used as medical or any other advice. Nothing in the journal or on this website shall be deemed to be a recommendation of, endorsement of, or a representation as to a third party’s qualifications, services, products, offerings, or any other information or claim.
- The Journal reserves the right, at its sole discretion, to change the terms and conditions of this agreement at any time without notice and your access to this website will be deemed to be your acceptance of and agreement to any changed terms and conditions.
Policy of Rovedar Article Processing Charge
The Rovedar model of high-quality publishing is founded on the principles of open science and sustained by Article Processing Charges (APCs). All newly-established journals in Rovedar are free of charge as supported by Rovedar Publishing company. Rovedar is a debt-free company and is not repaying loans or investments, but as a high-quality open-access publisher, it should pay for journal operations of newly established journals (15%), publication costs (10%), communication (5%), IT & innovation (12%), growth (16%), general & administration expenditure (5%), discounts and waivers (23%), differential article type pricing structure (2%), and general costs, such as membership in international publishing organizations and tax (12%).
Rovedar do not allow commercial advertising in its journals.
Rovedar has a policy to allow anonymous reporting of any concerns about financial impropriety, corruption, or other serious problems at the organization. If you have such a concern, please report it at: firstname.lastname@example.org
Rovedar’s CrossMark Policy
CrossMark is a multi-publisher initiative to provide a standard way for readers to locate the authoritative version of an article or other published content. By applying the CrossMark logo, Rovedar is committing to maintaining the content it publishes and to alerting readers to changes if and when they occur.
Clicking the CrossMark logo on a document will tell you its current status and may also give you additional publication-record information about the document. The Rovedar content that will have the CrossMark logo is restricted to current and future journal content and is limited to specific publication types.
For more information on CrossMark, please visit the CrossMark site.
For general author guidelines and information, please see: Publishing with Rovedar